Downloads: 9 | Views: 255 | Weekly Hits: ⮙3 | Monthly Hits: ⮙4
Review Papers | Medicine | Brazil | Volume 12 Issue 8, August 2023 | Popularity: 5.3 / 10
Clomiphene Citrate in Obesity - Associated Hypogonadism
Mateus Andrade Misson, Carlos Oliveira Leal Neto, Lucas Querino Wirz, Daniel Martins Borges, Thalita Leal Leite Pimenta
Abstract: This study investigates the benefits of Clomiphene Citrate CC in treating obesity-associated secondary hypogonadism. An integrative review was conducted, focusing on pharmacodynamic principles, risk-benefit, safety, and therapeutic effectiveness. The study concludes that CC is a safe and effective therapy for hypogonadotropic hypogonadism, especially beneficial for those desiring fatherhood.
Keywords: Hypogonadism. Male Obesity, ClomiphenCitrat. Fertility, Hypothalamic-Pituitary-Gonadal Axis
Edition: Volume 12 Issue 8, August 2023
Pages: 61 - 66
DOI: https://www.doi.org/10.21275/SR23729182057
Make Sure to Disable the Pop-Up Blocker of Web Browser
